We have reported that TLR2-agonist innate immune priming also re-calibrates BEC response to RV infection, characterised by rapid NF-κB activation and IFN-λ production that enhances control of viral infection in vitro and in vivo28. This evidence concerns the gene TLR2 and viral infectious disease.